Three Bridge Wealth Advisors, LLC Aclaris Therapeutics, Inc. Transaction History
Three Bridge Wealth Advisors, LLC
- $384 Million
- Q3 2025
A detailed history of Three Bridge Wealth Advisors, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Three Bridge Wealth Advisors, LLC holds 714,823 shares of ACRS stock, worth $1.44 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
714,823Holding current value
$1.44 Million% of portfolio
0.35%Shares
1 transactions
Others Institutions Holding ACRS
# of Institutions
100Shares Held
88.3MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN14.3MShares$28.6 Million15.31% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$19.4 Million0.02% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$17.9 Million2.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.66MShares$13.4 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.77MShares$9.59 Million0.46% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $134M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...